DRTS logo

ALPHA TAU MEDICAL LTD

DRTSNASDAQ
πŸ† #2252 by market capEarnings Mar 8US Equity
$11.77β–² $0.46 (+4.07%)
Market closed Β· at close
πŸ””
Track DRTS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 4.1%
7dβ–Ό 12.1%
14dβ–Ό 14.3%
30dβ–Ό 10.7%
ytdβ–² 139.0%
1yβ–² 220.3%
🏦Market Cap
$1.09B
Small Cap
πŸ“ˆRevenue Growth (YoY)
0.0%
Slowing
πŸ“ŠGross Margin
0.0%
Thin
πŸ’΅FCF Margin
0.0%
Thin
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
44
Weak

Trading Snapshot

Day Range
$11.57 – $12.04
52-Week Range
$3.65 – $15.79
Volume (shares)
19,325
Avg Volume (shares)
β€”
Shares Outstanding
92.5M
Next Earnings
2027-03-08

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
-9.6
P/S Ratio
0.0x
EPS (TTM)
$-1.20
Dividend Yield
0.00%
Dilution (1yr)
+22.2%
DRTS logo

ALPHA TAU MEDICAL LTD

DRTS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$42Mβ–² +17.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$33Mβ–² +48.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
85.7Mβ–² +22.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2Mβ–Ό βˆ’$3M YoY
StockOtter Β· stockotter.space

About ALPHA TAU MEDICAL LTD

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
44/100
Analyst data unavailable.

Latest News & Updates

News unavailable.